Discordant results of tests for tuberculosis reconsidered - Authors' reply

Affiliations

¹ US Embassy, Panchsheel Marg, Shantipath, Chanakyapuri, New Delhi, Delhi 110021, India; Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: gtb9@cdc.gov.
² Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
³ TB Control Program, Public Health-Seattle and King County, Seattle, WA, USA.
⁴ Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
⁵ Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, CA, USA.
⁶ Division of Global Public Health, School of Medicine, University of California, San Diego, CA, USA.
⁷ Denver Health and Hospital Authority, Denver, CO, USA.

Comment

Christine S Ho et al. Lancet Infect Dis. 2022 Feb.

. 2022 Feb;22(2):164-165.

doi: 10.1016/S1473-3099(21)00805-7.

¹ US Embassy, Panchsheel Marg, Shantipath, Chanakyapuri, New Delhi, Delhi 110021, India; Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: gtb9@cdc.gov.
² Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
³ TB Control Program, Public Health-Seattle and King County, Seattle, WA, USA.
⁴ Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
⁵ Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, CA, USA.
⁶ Division of Global Public Health, School of Medicine, University of California, San Diego, CA, USA.
⁷ Denver Health and Hospital Authority, Denver, CO, USA.

No abstract available

Conflict of interest statement

We declare no competing interests.

Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study.
Ho CS, Feng PI, Narita M, Stout JE, Chen M, Pascopella L, Garfein R, Reves R, Katz DJ; Tuberculosis Epidemiologic Studies Consortium. Ho CS, et al. Lancet Infect Dis. 2022 Jan;22(1):85-96. doi: 10.1016/S1473-3099(21)00145-6. Epub 2021 Sep 6. Lancet Infect Dis. 2022. PMID: 34499863 Free PMC article.
Discordant results of tests for tuberculosis reconsidered.
Arend SM, Uzorka JW. Arend SM, et al. Lancet Infect Dis. 2022 Feb;22(2):164. doi: 10.1016/S1473-3099(21)00807-0. Lancet Infect Dis. 2022. PMID: 35092786 No abstract available.